Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former Cambridge Biotech chief finance officer is sentenced:

This article was originally published in Clinica

Executive Summary

Peter Hartman, former chief finance officer of now-defunct Cambridge Biotech, has received five years' probation and a fine of $540,000 for his part in falsely inflating the company's revenues. The judge in the case said that Mr Hartman would have received a lengthy prison term, but for the fact that he has AIDS. The company has no connection with bioMerieux Vitek's subsidiary of the same name.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel